$20.300
-1.257 (-6.19%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -1.64, suggesting MLYS is Strong sell.
Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 23.93, while Mineralys Therapeutics Inc (MLYS) share price is $—, making it Sell.
Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 26.03, while Mineralys Therapeutics Inc (MLYS) share price is $—, making it Sell.
Technical Analysis for MLYS
AI Technical MLYSAs of 2026-10-17, the technical board for Mineralys Therapeutics Inc (MLYS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $20.30 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 31.891, MACD stands at -1.637 (Sell), Stochastic %K stands at 10.295 (Buy), Stochastic %D stands at 10.126 and CCI stands at -109.781 (Buy).
MLYS trades below the 60-day SMA (26.03) and below the 200-day SMA (27.67). Immediate resistance sits at Classic R1 23.89, then R2 25.89. Support sits at Classic S1 20.01, then S2 18.13.
Mineralys Therapeutics Inc (MLYS) Support & Resistance Level
Mineralys Therapeutics Inc (MLYS) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 31.891 |
| STOCHk_14_3_3 | 10.295 |
| STOCHd_14_3_3 | 10.126 |
| CCI_20 | -109.781 |
| AO_5_34 | -4.299 |
| MOM_10 | -3.330 |
| MACD_12_26_9 | -1.637 |
Mineralys Therapeutics Inc (MLYS) Relative Strength Index (RSI_14) is 31.891, creating a Neutral signal.
Mineralys Therapeutics Inc (MLYS) Stochastic %K is 10.295, creating a Buy signal.
Mineralys Therapeutics Inc (MLYS) Stochastic %D is 10.126, creating a Buy signal.
Mineralys Therapeutics Inc (MLYS) CCI_20 is -109.781, creating a Buy signal.
Mineralys Therapeutics Inc (MLYS) Awesome Oscillator (AO) is -4.299, creating a Sell signal.
Mineralys Therapeutics Inc (MLYS) Momentum (MOM) is -3.330, creating a Sell signal.
Mineralys Therapeutics Inc (MLYS) Moving Average Convergence Divergence (MACD) is -1.637, creating a Sell signal.
Mineralys Therapeutics Inc (MLYS) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 21.186 | Sell |
| MA_10 | 21.902 | Sell |
| MA_20 | 23.933 | Sell |
| MA_60 | 26.032 | Sell |
| MA_200 | 27.674 | Sell |
| MA_250 | 30.145 | Sell |
Mineralys Therapeutics Inc (MLYS) 5-Day simple moving average is 21.186, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
Mineralys Therapeutics Inc (MLYS) 10-Day simple moving average is 21.902, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 23.933, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 26.032, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
Mineralys Therapeutics Inc (MLYS) 200-Day simple moving average is 27.674, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
Mineralys Therapeutics Inc (MLYS) 250-Day simple moving average is 30.145, while Mineralys Therapeutics Inc (MLYS) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.